Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data

Näytä muut versiot (1)

Background: The efficacy of RTS,S/AS01 as a vaccine for malaria is being tested in a phase 3 clinical trial. Early results show significant, albeit partial, protection against clinical malaria and severe malaria. To ascertain variations in vaccine efficacy according to covariates such as transmissio...

Bibliografiset tiedot
Päätekijät:	Bejon, P, White, M, Olotu, A, Bojang, K, Lusingu, J, Salim, N, Otsyula, N, Agnandji, S, Asante, K, Owusu-Agyei, S, Abdulla, S, Ghani, A
Aineistotyyppi:	Journal article
Julkaistu:	2013

Samankaltaisia teoksia

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
Tekijä: Bejon, P, et al.
Julkaistu: (2013)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
Tekijä: White, M, et al.
Julkaistu: (2014)

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data.
Tekijä: Warimwe, G, et al.
Julkaistu: (2013)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
Tekijä: Olotu, A, et al.
Julkaistu: (2010)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
Tekijä: Bejon, P, et al.
Julkaistu: (2009)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
Tekijä: Olotu, A, et al.
Julkaistu: (2013)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
Tekijä: Olotu, A, et al.
Julkaistu: (2016)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection
Tekijä: White, M, et al.
Julkaistu: (2013)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
Tekijä: Bejon, P, et al.
Julkaistu: (2008)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
Tekijä: Stephaney Gyaase, et al.
Julkaistu: (2021-01-01)

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".
Tekijä: Bejon, P, et al.
Julkaistu: (2009)

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.
Tekijä: Bejon, P, et al.
Julkaistu: (2011)

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
Tekijä: Ndungu, F, et al.
Julkaistu: (2012)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children
Tekijä: Olotu, A, et al.
Julkaistu: (2014)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
Tekijä: Vekemans, J, et al.
Julkaistu: (2011)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Tekijä: Olotu, A, et al.
Julkaistu: (2011)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Tekijä: Lusingu, J, et al.
Julkaistu: (2010)

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
Tekijä: Duncan, C, et al.
Julkaistu: (2011)

The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection.
Tekijä: Michael T White, et al.
Julkaistu: (2013-01-01)

PHASE IIB, RANDOMIZED, DOUBLE-BLIND TRIAL TO ASSESS THE EFFICACY, SAFETY AND IMMUNOGENICITY OF THE CANDIDATE MALARIA VACCINE RTS,S/AS01 IN KENYAN AND TANZANIAN CHILDREN
Tekijä: Bejon, P, et al.
Julkaistu: (2008)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
Tekijä: Agnandji, S, et al.
Julkaistu: (2012)

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.
Tekijä: Horowitz, A, et al.
Julkaistu: (2012)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
Tekijä: Daniel Ansong, et al.
Julkaistu: (2011-04-01)

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.
Tekijä: Agnandji, S, et al.
Julkaistu: (2011)

Statistical methodology for the evaluation of vaccine efficacy in a phase III multi-centre trial of the RTS, S/AS01 malaria vaccine in African children.
Tekijä: Lievens, M, et al.
Julkaistu: (2011)

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01E on blood stage immunity in young Kenyan children
Tekijä: Ndungu, F, et al.
Julkaistu: (2019)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
Tekijä: Seth Owusu-Agyei, et al.
Julkaistu: (2010-01-01)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
Tekijä: Carlota Dobaño, et al.
Julkaistu: (2019-05-01)

Randomized controlled trial of RTS,S/AS02D and RTS,S/AS01E malaria candidate vaccines given according to different schedules in Ghanaian children.
Tekijä: Seth Owusu-Agyei, et al.
Julkaistu: (2009-10-01)

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria.
Tekijä: Ally Olotu, et al.
Julkaistu: (2011-01-01)

Avidity of anti-circumsporozoite antibodies following vaccination with RTS,S/AS01E in young children.
Tekijä: Ally Olotu, et al.
Julkaistu: (2014-01-01)

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa
Tekijä: Otieno, L, et al.
Julkaistu: (2019)

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa
Tekijä: Guerra Mendoza, Y, et al.
Julkaistu: (2019)

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care
Tekijä: Vekemans Johan, et al.
Julkaistu: (2011-08-01)

RTS,S: the first malaria vaccine
Tekijä: Fidel Zavala
Julkaistu: (2022-01-01)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
Tekijä: John N Waitumbi, et al.
Julkaistu: (2009-11-01)

What is the efficacy of the RTS,S malaria vaccine?
Tekijä: Duncan, C, et al.
Julkaistu: (2011)

What is the efficacy of the RTS,S malaria vaccine?
Tekijä: Duncan, C, et al.
Julkaistu: (2011)

Correction: Safety of the Malaria Vaccine Candidate, RTS,S/AS01 in 5 to 17 Month Old Kenyan and Tanzanian Children.
Tekijä: John Lusingu, et al.
Julkaistu: (2010-01-01)

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.
Tekijä: John Lusingu, et al.
Julkaistu: (2010-11-01)